For the Inventor, By the Inventor

Enter assignee name

Singapore, Singapore

Wave Life Sciences Ltd.

USPTO Granted Patents = 41

% Expired Patents = 4.9

EPO Patents = 5

Trademarks = 6

Forward Citations = 576

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Naoki Iwamoto (25 out of 25 patents)

Chandra Vargeese (22 out of 61 patents)

David Charles Donnell Butler (20 out of 22 patents)

4. Subramanian Marappan (14 out of 21 patents)

5. Gregory Lawrence Verdine (14 out of 85 patents)

6. Meena (12 out of 12 patents)

7. Pachamuthu Kandasamy (11 out of 33 patents)

8. Genliang Lu (11 out of 30 patents)

9. Jason Jingxin Zhang (10 out of 11 patents)

10. Sethumadhavan Divakaramenon (10 out of 10 patents)

11. Gopal Reddy Bommineni (9 out of 9 patents)

12. Christopher J Francis (8 out of 8 patents)

13. Nenad Svrzikapa (8 out of 8 patents)

14. Mamoru Shimizu (7 out of 12 patents)

15. Mamoru Shimizu (7 out of 7 patents)

Core Competencies:

Oligonucleotide Compositions

Synthesis Methods

Chiral Design

Phosphoramidite

Nucleic Acid Prodrugs

Functionalized Nucleic Acids

Asymmetric Auxiliary Group

Chiral Control

Oligonucleotide Preparation

Chiral Auxiliaries

Compounds

Technologies

41 patents: Sort by Forward Citations

1. 12760305 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF (2026-10-13),

2. 12735703 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF (2026-09-15),

3. 12674168 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF (2026-07-07),

4. 12637672 - Oligonucleotide compositions and methods thereof (2026-05-26),

5. 12590115 - TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION (2026-03-31),

6. 12583883 - Asymmetric auxiliary group (2026-03-24),

7. 12552743 - Oligonucleotide compositions and methods of use thereof (2026-02-17),

8. 12486505 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF (2025-12-02),

9. 12473321 - COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS (2025-11-18),

10. 12435105 - Technologies for oligonucleotide preparation (2025-10-07),

11. 12428442 - Compounds, compositions and methods for synthesis (2025-09-30),

12. 12403156 - Oligonucleotides, compositions and methods thereof (2025-09-02),

13. 12391942 - Oligonucleotide compositions and methods of use thereof (2025-08-19),

14. 12180472 - Chiral design (2024-12-31),

15. 11873316 - Compositions and methods for phosphoramidite and oligonucleotide synthesis (2024-01-16),

Company Overview

Wave Life Sciences Ltd. is a biotechnology company based in Singapore, specializing in the development of innovative therapies for genetic diseases. The company focuses on advancing its proprietary nucleic acid technologies, particularly in the areas of RNA modulation and gene editing. By leveraging its expertise in these domains, Wave aims to address unmet medical needs and improve patient outcomes through precision medicine. Its research initiatives are designed to create transformative treatments that target the underlying causes of diseases at the molecular level.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

41 Patents

#72 in Singapore

#72 in Singapore

#16,725 in the World

Singapore, Singapore

Wave Life Sciences Ltd.

Forward Citations = 576

58 inventors:

Naoki Iwamoto (25 out of 25 patents)

Chandra Vargeese (22 out of 61 patents)

David Charles Donnell Butler (20 out of 22 patents)

4. Subramanian Marappan (14 out of 21 patents)

5. Gregory Lawrence Verdine (14 out of 85 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Wave Life Sciences Ltd.. Retrieved from https://idiyas.com/company/wave-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…